Lawrence Blatt

North America, California, United States

Description

Lawrence M. Blatt is the chief executive officer of Aligos Therapeutics. Lawrence M. Blatt attended University of La Verne.

Lawrence Blatt has made 1 investments, with 0 in the past 12 months and 0% as lead.

FAQ

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

North America, California, United States, San Francisco

Co-Investments: 1

North America, Connecticut, United States, Greenwich

Co-Investments: 1

Europe, Basel-Stadt, Switzerland, Basel

Co-Investments: 1

North America, New York, United States, New York

Co-Investments: 1

San Francisco, California, United States

Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.

Biotechnology

Post Ipo EquityOct 23, 2023

Amount Raised: $92,000,000